Promise for new fluorescence agent for the diagnosis of neoplastic lesions in the colon is seen in a phase II dose-finding study.  Hexaminolevulinate-induced fluorescence colonoscopy resulted in finding detecting 97.8% (91/93) of all histologically confirmed lesions found compared to the 59.1% (55/93) of all lesions seen using white light diagnosis.  Dr. Mayinger and her co-authors present this and other findings in their recently published  article in Endoscopy.
 
Mayinger B, Neumann F, Kastner C, Haider T, Schwab T: Hexaminolevulinate-induced fluorescence colonoscopy versus white light endoscopy for diagnosis of neoplastic lesions in the colon. Endoscopy 2010; 42: 28-33.


Link to the article: https://www.thieme-connect.de/ejournals/abstract/endoscopy/doi/10.1055/s-0029-1243804